Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; BMI, body mass index; NAFLD, nonalcoholic fatty liver disease; MS, metabolic syndrome; DM2, type 2 diabetes mellitus; CVD, cardiovascular disease; ALT, alanine aminotransferase; SBP, systolic blood pressure; HDL, high-density lipoprotein; DBP, diastolic b
مقالات ISI NAFLD، بیماری کبدی چربی غیرالکلی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; NAFLD, nonalcoholic fatty liver disease; OPN, osteopontin; TGF-β, transforming growth factor β; αSMA, alpha smooth muscle actin; MCD diet, methionine choline deficient diet; FFPE, formalin-fixed, paraffin embedded; HPF, high-powered field; shScr, short-ha
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; T2DM, type 2 diabetes mellitus; CVD, cardiovascular disease; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; HSCs, hepatic stellate cells; ER, endoplasmic reticulum; UPR, unfolded protein response; MCD, methionine- and choline
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; NAFLD, nonalcoholic fatty liver disease; FA, fatty acid; HFD, high fat diet; CD, Control diet; HE, hematoxylin and eosin; GC, gas chromatography; TFA, total fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; SFA, saturated
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; Nonalcoholic Fatty Liver Disease; Nonalcoholic Steatohepatitis; Children; AdultsALT, alanine aminotransferases; HCC, hepatocellular carcinoma; NAFLD, nonalcoholic fatty liver disease; NHANES, National Health and Nutrition Examination Survey; NAS, NAFLD Ac
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; NAFLD, nonalcoholic fatty liver disease; NAFL, nonalcoholic fatty liver; NASH, nonalcoholic steatohepatitis; T2DM, type 2 diabetes mellitus; MetS, metabolic syndrome; CVD, cardiovascular disease; LDL-C, low-density lipoprotein cholesterol; ULN, upper limi
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; T2D, type 2 diabetes; NAFLD, nonalcoholic fatty liver disease; CVD, cardiovascular disease; MS, metabolic syndrome; FFA, free fatty acids; NW, normal weight; HO, metabolically healthy obese; UO, metabolically unhealthy obese; SFA, saturated fatty acid; UF
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; BAT, brown adipose tissue; CYP, cytochrome P450; DAG, diacylglycerol; DNP, 2,4-dinitrophenol; FAO, fatty acid oxidation; DNPME, 2,4-dinitrophenol-methyl ether; NAFLD, nonalcoholic fatty liver disease; OXPHOS, oxidative phosphorylation; PKCɛ, protein kinas
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; ALT, alanine aminotransferase; ER, endoplasmic reticulum; FFA, free fatty acid; HFD, high-fat diet; HSP70, heat shock protein 70; mtHSP70, mitochondrial heat shock protein 70; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; PA
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; ApoC3, apolipoprotein C III; CK-18, cytokeratin-18; DAG, diacylglycerol; ER, endoplasmic reticulum; HCC, hepatocellular carcinoma; LPS, lipopolysaccharide; LXR, liver X receptor; MET, metabolic equivalent of task; NAFLD, nonalcoholic fatty liver disease;
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; NASH; Histology; Diagnosis; PrognosisAH, alcoholic hepatitis; ALD, alcoholic liver disease; HCC, hepatocellular carcinoma; IL, interleukin; K, keratin; MIR, microRNA; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; Microbiota; Endotoxin; Alcoholic SteatohepatitisFXR, farnesoid X receptor; IL, interleukin; LPS, lipopolysaccharide; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; PAMP, pathogen-associated molecular pattern; PCR, polymerase
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; NAFLD; ALD; MortalityAAH, acute alcoholic hepatitis; ALD, alcoholic fatty liver disease; BMI, body mass index; HCC, hepatocellular carcinoma; HRQL, health-related quality of life; NAFLD, nonalcoholic fatty liver disease; NHANES, National Health and Nutrit
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; Nonalcoholic Fatty Liver Disease; Lipotoxicity; Wound-Healing Response; MisrepairNAFL, nonalcoholic fatty liver; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; SHH, sonic hedgehog; SMO, smoothened, frizzled class receptor; TN
Association of rs5764455 and rs6006473 polymorphisms in PARVB with liver damage of nonalcoholic fatty liver disease in Han Chinese population
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; NAFLD, nonalcoholic fatty liver disease; SNP, single nucleotide polymorphism; TC, total cholesterol; TG, triglyceride; HDL, high density lipoprotein; LDL, low density lipoprotein; TBIL, total bilirubin; DBIL, direct bilirubin; γ-GT, gamma glutamyltransfer
MDG-1, an Ophiopogon polysaccharide, alleviates hyperlipidemia in mice based on metabolic profile of bile acids
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; FXR, farnesoid X receptor; LXR, liver X receptor; NAFLD, nonalcoholic fatty liver disease; FOS, fructooligosaccharides; DIO, diet-induce obese; UPLC–MS, ultra-performance liquid chromatography mass-spectrometry; CA, cholic acid; CDCA, chenodeoxycholic aci
Identification and differential expression of microRNAs associated with fat deposition in the liver of Wistar rats with nonalcoholic fatty liver disease
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; NAFLD, nonalcoholic fatty liver disease; miRNA, microRNA; GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; TG, triglycerides; BGI, Beijing genomics institute; GEO, gene expression omnibus; NCBI, national centers for bioinformatics informa
Computerized tomography measured liver fat is associated with low levels of N-terminal pro-brain natriuretic protein (NT-proBNP). Multi-Ethnic Study of Atherosclerosis
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; Natriuretic peptides; Non-alcohol fatty liver disease; NT-proBNP; Hounsfield unitsNT-proBNP, N-terminal pro B-type natriuretic peptide; MESA, Multi-Ethnic Study of Atherosclerosis; NAFLD, nonalcoholic fatty liver disease; RP, relative prevalence; IL-6, in
PNPLA3 gene in liver diseases
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; GWAS, genome-wide association studies; CHC, chronic hepatitis C; SNP, single nucleotide polymorphism; HCV, hepatitis C virus; PNPLA3, patatin-like phospholipase domain containing 3; NAFLD, nonalcoholic fatty liver disease; ALT, alanine aminotransferase; B
Purinergic receptor X7 mediates leptin induced GLUT4 function in stellate cells in nonalcoholic steatohepatitis
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; CYP2E1, cytochrome P450, family 2, subfamily E, polypeptide 1; NASH, nonalcoholic steatohepatotitis; P2X7r, purinergic receptor X7; GLUT4, glucose transporter 4; IL-1β, interleukin 1β; BDCM, bromodichloromethane; NAFLD, nonalcoholic fatty liver disease; C
Increased circulating adiponectin in males with chronic HCV hepatitis
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; HCV, hepatitis C virus; CHC, chronic HCV hepatitis; IR, insulin resistance; T2DM, type 2 diabetes mellitus; NAFLD, nonalcoholic fatty liver disease; ADIPOQ, adiponectin gene; BMI, body mass index; AST, aspartate aminotransferases; ALT, alanine aminotransf
Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; TRAF3; Obesity; Insulin; Liver; Inflammation; Diabetes; GluconeogenesisTRAF3, TNF receptor-associated factor 3; HFD, high fat diet; NAFLD, nonalcoholic fatty liver disease; HKO, hepatocyte-specific TRAF3 knockout; GTT, glucose; ITT, insulin; PTT, pyruvate
Hepatitis B virus infection in patients with metabolic syndrome: A complicated relationship. Results of a population based study
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; HDL, high density lipoproteins; LDL, low density lipoproteins; TG, triglycerides; MS, metabolic syndrome; HBI, hepatitis B infection; HBV, hepatitis B virus; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; AST, aspartate amino
Dietary α-tocopherol and atorvastatin reduce high-fat-induced lipid accumulation and down-regulate CD36 protein in the liver of guinea pigs
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; NAFLD, nonalcoholic fatty liver disease; CD36, cluster of differentiation 36 (fatty acid translocase/scavenger receptor); αT, α-tocopherol; ATV, atorvastatin; TAG, triacylglycerols; GSH, reduced glutathione; GSSG, glutathione disulfide; MDA, malondialdehy
The value of neck circumference (NC) as a predictor of non-alcoholic fatty liver disease (NAFLD) *
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; Neck circumference; Waist circumference; Non-alcoholic fatty liver disease; Insulin resistanceNC, Neck circumference; NAFLD, Nonalcoholic fatty liver disease; NHtR, Neck circumference-height ratio; T2DM, Type 2 diabetes mellitus; IR, Insulin resistance; M
MRI evaluation of fatty liver in day to day practice: Quantitative and qualitative methods
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; BMI, body mass index; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; PDFF, proton density fat fraction; MRI, magnetic resonance imaging; MRS, magnetic resonance spectroscopy; GRE, gradient echo; TE, echo time; TR, repetition
Early detection of liver steatosis by magnetic resonance imaging in rats infused with glucose and Intralipid solutions and correlation to insulin levels
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; FF, Fat fraction; GLU + IL, Glucose + Intralipid; IP, In-phase; MR, Magnetic resonance; MRI, Magnetic resonance imaging; MRS, Magnetic resonance spectroscopy; NAFLD, Nonalcoholic fatty liver disease; NASH, Nonalcoholic steatohepatitis; OP, Opposed-phase;
Gly482Ser mutation impairs the effects of peroxisome proliferator–activated receptor γ coactivator-1α on decreasing fat deposition and stimulating phosphoenolpyruvate carboxykinase expression in hepatocytes
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; NAFLD, nonalcoholic fatty liver disease; ACC1, acetyl-CoA carboxylase 1; FAS, fatty acid synthase; PPARγ, peroxisome proliferator–activated receptor γ; PGC-1α, peroxisome proliferator–activated receptor γ coactivator-1α; PEPCK, phosphoenolpyruvate carboxy
Obstructive Sleep Apnea : A Cardiometabolic Risk in Obesity and the Metabolic Syndrome
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; cardiovascular risk; metabolic syndrome; obesity; sleep apneaBMI, body mass index; CPAP, continuous positive airway pressure; eNOS, endothelial nitric oxide synthase; NAFLD, nonalcoholic fatty liver disease; NO, nitric oxide; OSA, obstructive sleep apnea
Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; ARE, Antioxidant response element; Nrf2, Nuclear factor erythroid 2-like 2; KO, Knockout; WT, Wild-type; P450, Cytochrome P450; NASH, Nonalcoholic steatohepatitis; NAFLD, Nonalcoholic fatty liver disease; co-IP, Co-immunoprecipitationCoumarin 7-hydroxylas
Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: An input for novel therapies
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; HSCs, hepatic stellate cells; EMT, epithelial to mesenchymal transition; ECM, extracellular matrix; LPS, lipopolysaccharide; TLRs, Toll-like receptors; TIR, Toll/IL-1 receptor; P
Phycocyanin prevents hypertension and low serum adiponectin level in a rat model of metabolic syndrome
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; ANOVA, analysis of variance; C/EBPα, CCAAT/enhancer binding protein α; ELISA, enzyme-linked immunosorbent assay; eNOS, endothelial nitric oxide synthase; HDL-C, high-density lipoprotein cholesterol; NAFLD, nonalcoholic fatty liver disease; NAS, NAFLD acti
Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; BA, bile acid; CA, cholic acid; DCA, deoxycholic acid; CDCA, chenodeoxycholic acid; TCA, taurocholic acid; TDCA, taurodeoxycholic acid; GCA, glycocholic acid; GDCA, glycodeoxycho
Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; AHA, American Heart Association; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BIB, Bioenterics intragastric balloon; BMI, body mass index; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis
Screening for liver fibrosis by using FibroScan® and FibroTest in patients with diabetes
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; GGT, γ-glutamyl-transpeptidase; IQR, interquartile range; kPa, kilopascals; NAFLD, nonalcoholic fatty liver disease; OR, odds ratio; PT, prothrombin timeCirrhosis; Diabe
Low concentrations of bisphenol A induce lipid accumulation mediated by the production of reactive oxygen species in the mitochondria of HepG2 cells
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; BPA, bisphenol A; ΔΨM, mitochondrial transmembrane potential; ER, estrogen receptor; E2, estradiol-17β; GSH, glutathione; HNE, hydroxynonenal; IL, Interleukin; LPO, lipoperoxidation; NAFLD, Nonalcoholic fatty liver disease; NO, nitric oxide; ROS, reactive
Dietary protein restriction induces steatohepatitis and alters leptin/signal transducers and activators of transcription 3 signaling in lactating rats
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; PR, protein restriction; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; AMPK, 5′-adenosine monophosphate-activated protein kinase; VLDL, very-low-density lipoprotein; HSCs, hepatic stellate cells; NADPH, nicotinamide adenine
Ursodeoxycholic acid with vitamin E in patients with nonalcoholic steatohepatitis: Long-term results
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; FFAs, free fatty acids; GGT, γ glutamyl-transferase; NAFLD, nonalcoholic fatty liver disease; NAS, NAFLD activity score; NASH, nonalcoholic steatohepatitis; UDCA, ursode
Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; AOX, acyl-CoA oxidase; ALT, alanine aminotransferase; FFA, free fatty acid; iNOS, inducible nitric oxide synthase; L-FABP, liver-fatty acid binding protein; MCD, methionine-choline deficient; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic ste
MicroRNAs in Liver Disease
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; Chronic Liver Disease; Liver Fibrosis; Cirrhosis; Hepatocellular CarcinomaALD, alcoholic liver disease; HNF, hepatocyte nuclear factor; LNA, locked nucleic acid; miRNA, microRNA; miRNP, protein-microRNA complex; NAFLD, nonalcoholic fatty liver disease; qR
Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; Liver Disease; Organ Transplantation; Complications of Obesity; SteatosisBMI, body mass index; CC, cryptogenic cirrhosis; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; SRTR, Scientific Registry of Transplant Recipients
The soluble fiber complex PolyGlycopleX lowers serum triglycerides and reduces hepatic steatosis in high-sucrose-fed rats
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; ANOVA, analysis of variance; HbA1c, glycated hemoglobin; NAFLD, nonalcoholic fatty liver disease; PGX, PolyGlycoplex; SCFA, short-chain fatty acids; TG, triglycerideViscous fiber; Hepatic steatosis; Hypertriglyceridemia; Functional fiber; Rat
Endoscopic visceral fat removal as therapy for obesity and metabolic syndrome: a sham-controlled pilot study (with video)
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; NAFLD, nonalcoholic fatty liver disease; NOTES, natural orifice transluminal endoscopic surgery; TNF, tumor necrosis factor; VF, visceral fat
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; NAFLD; NASH: Prevalence; Ultrasound: Liver Biopsy; Fatty Liver Disease; Hepatic SteatosisALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis
Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; CD, control diet; 2D-DIGE, two-dimensional differential in-gel electrophoresis; HFLD, high-fat lard diet; MALDI-TOF/MS-MS, matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry; NAFLD, nonalcoholic fatty liver disease; NASH,
Dissociation Between Intrahepatic Triglyceride Content and Insulin Resistance in Familial Hypobetalipoproteinemia
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; Steatosis; Insulin sensitivity; Obesity; ClampapoB, apolipoprotein B; BMI, body mass index; IHTG, intrahepatic triglycerides; FFM, fat-free mass; FHBL, familial hypobetalipoproteinemia; NAFLD, nonalcoholic fatty liver disease; Rd, rate of disappearance; T
The fatty acid composition of plasma cholesteryl esters and estimated desaturase activities in patients with nonalcoholic fatty liver disease and the effect of long-term ezetimibe therapy on these levels
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; CEs, Cholesteryl esters; DAG, Diacylglycerols; HOMA-R, Homeostasis model assessment of insulin resistance; IRI, Immunoreactive insulin; NAS, NAFLD activity score; emlDL, Electronegative charge modified-LDL; NAFLD, Nonalcoholic fatty liver disease; NASH, N
Omentin: A Novel Link Between Inflammation, Diabesity, and Cardiovascular Disease
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; AT, adipose tissue; CRP, C-reactive protein; DM, diabetes mellitus; FFA, free fatty acid; IGT, impaired glucose tolerance; mRNA, messenger ribonucleic acid; NAFLD, nonalcoholic fatty liver disease; NF-κB, nuclear factor κ-light-chain-enhancer of activated
Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; PAI-1, plasminogen activator inhibitor-1; sICAM-1, soluble intercellular adhesion molecule-1; sCD40L, soluble CD40 ligand; ELISA, enzyme-linked immuno-sorbent assayICAM-1; PAI-1;
HFE Genotype, Parenchymal Iron Accumulation, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Keywords: NAFLD، بیماری کبدی چربی غیرالکلی; Hepatic Fibrosis; hfe Gene; Iron Overload; Nonalcoholic Fatty Liver DiseaseBMI, body mass index; GGT, γ-glutamyltranspeptidase; HFE, hemochromatosis gene; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis